𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of the Fresenius cell separator AS 104 for harvesting peripheral blood stem cells in pediatric patients

✍ Scribed by Leibundgut, Kurt; Muff, Joseph; Hirt, Andreas; Mitschulat, Heike; Nydegger, Urs E.; Lüthy, Annette Ridolfi; Tobler, Andreas; Wagner, Hans P.

Book ID
122295710
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
655 KB
Volume
15
Category
Article
ISSN
0955-3886

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of a new protocol for periphe
Evaluation of a new protocol for peripheral blood stem cell collection with the Fresenius AS 104 cell separator
✍ Giacomo Menichella; Marco Lai; Luca Pierelli; Riccardo Serafini; Mariangela Vitt 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

In this report we analyzed sixty leukapheresis procedures on 35 patients with a new protocol for the Fresenius AS 104. Yields and efficiencies for MNC, CD 34+ cells, and CFU-GM indicate that the new protocol is able to collect large quantities of hemopoietic progenitors. Procedures were performed pr

International Forum. Evaluation of the s
International Forum. Evaluation of the single needle procedure in plateletpheresis with the fresenius as 104 blood cell separator
✍ Dr. Rainer Moog; Norbert Müller 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

The aim of the present study was to evaluate the single needle (SN) procedure for plateletpheresis with the AS 104 blood cell separator. One hundred fifty-seven platelet collections with different protocols were carried out and analysed with respect to platelet yield, separation efficiency, leukocyt

Cord blood and peripheral blood as a sou
Cord blood and peripheral blood as a source of hematopoietic stem cells for pediatric patients
✍ Ka Wah Chan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 267 KB

reported to have specific effect on megakaryocytopoiesis and enhance platelet recovery post chemotherapy. A mixture of growth factors are being evaluated for the ex vivo of periphera! progenitor cells to further reduce the period of marrow aplasia post therapy. Recombinant proteins are also helpful